Transaction DateRecipientSharesTypePriceValue
4th January 2021Bros. Advisors Lp Baker111,094Open or private sale$220.50$24,496,227.00
4th January 2021Bros. Advisors Lp Baker10,060Open or private sale$220.50$2,218,230.00
31st December 2020Bros. Advisors Lp Baker343Grant/award etc.$0.00
31st December 2020Bros. Advisors Lp Baker343Grant/award etc.$0.00
17th December 2020Igor Matushansky29,628Exercise of derivative$0.10$2,962.80
17th December 2020Igor Matushansky11,501Open or private sale$11.70$134,561.70
17th December 2020Igor Matushansky16,478Open or private sale$11.76$193,781.28
17th December 2020Igor Matushansky19,360Exercise of derivative$0.10$1,936.00
16th December 2020Igor Matushansky640Exercise of derivative$0.10$64.00
16th December 2020Igor Matushansky380Open or private sale$11.70$4,446.00
Hookipa Pharma
Hookipa Pharma logo

HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers. Its product include VaxWace, a replication-deficient viral vector. The company was founded by Rolf Zinkernagel in 2011.


Ticker: HOOK
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1760542
Employees: 56
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals